Gábor Gigler

821 total citations
26 papers, 656 citations indexed

About

Gábor Gigler is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Gábor Gigler has authored 26 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 9 papers in Neurology. Recurrent topics in Gábor Gigler's work include Neuroscience and Neuropharmacology Research (11 papers), Neuroinflammation and Neurodegeneration Mechanisms (9 papers) and Tryptophan and brain disorders (4 papers). Gábor Gigler is often cited by papers focused on Neuroscience and Neuropharmacology Research (11 papers), Neuroinflammation and Neurodegeneration Mechanisms (9 papers) and Tryptophan and brain disorders (4 papers). Gábor Gigler collaborates with scholars based in Hungary, France and United Kingdom. Gábor Gigler's co-authors include Gábor Szénási, György Lévay, László G. Hársing, Mihály Albert, Pàl Sohár, Katalin Sas, Péter Mátyus, István Gyertyán, József Toldi and Zsolt Jurányi and has published in prestigious journals such as Brain Research, British Journal of Pharmacology and Life Sciences.

In The Last Decade

Gábor Gigler

25 papers receiving 643 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gábor Gigler Hungary 14 231 205 156 124 88 26 656
Mitsuhiro Makino Japan 17 132 0.6× 204 1.0× 80 0.5× 119 1.0× 104 1.2× 36 739
Flóra Gölöncsér Hungary 17 142 0.6× 150 0.7× 144 0.9× 186 1.5× 43 0.5× 24 789
Marina Alesiani Italy 10 517 2.2× 357 1.7× 131 0.8× 117 0.9× 76 0.9× 12 925
Kazuyuki Tomisawa Japan 15 271 1.2× 317 1.5× 40 0.3× 83 0.7× 154 1.8× 51 846
Michael A. Ackley United States 13 401 1.7× 287 1.4× 45 0.3× 100 0.8× 99 1.1× 22 859
Helena Domin Poland 19 427 1.8× 304 1.5× 127 0.8× 116 0.9× 95 1.1× 42 819
Irena Romańska Poland 18 558 2.4× 268 1.3× 59 0.4× 88 0.7× 85 1.0× 52 927
Elena Meli Italy 15 380 1.6× 353 1.7× 228 1.5× 235 1.9× 174 2.0× 20 955
Maria Antonietta Stasi Italy 16 351 1.5× 361 1.8× 36 0.2× 38 0.3× 50 0.6× 31 814
Athanasios Metaxas Denmark 17 263 1.1× 314 1.5× 87 0.6× 93 0.8× 39 0.4× 40 723

Countries citing papers authored by Gábor Gigler

Since Specialization
Citations

This map shows the geographic impact of Gábor Gigler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gábor Gigler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gábor Gigler more than expected).

Fields of papers citing papers by Gábor Gigler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gábor Gigler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gábor Gigler. The network helps show where Gábor Gigler may publish in the future.

Co-authorship network of co-authors of Gábor Gigler

This figure shows the co-authorship network connecting the top 25 collaborators of Gábor Gigler. A scholar is included among the top collaborators of Gábor Gigler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gábor Gigler. Gábor Gigler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gacsályi, István, et al.. (2018). Persistent therapeutic effect of a novel α5-GABAA receptor antagonist in rodent preclinical models of vascular cognitive impairment. European Journal of Pharmacology. 834. 118–125. 14 indexed citations
2.
Gacsályi, István, Gábor Gigler, Katalin Nagy, et al.. (2017). Behavioural pharmacology of the α5-GABA A receptor antagonist S44819: Enhancement and remediation of cognitive performance in preclinical models. Neuropharmacology. 125. 30–38. 16 indexed citations
3.
Pataki, Ágnes, Balázs Mihalik, Gábor Gigler, et al.. (2017). Loop F of the GABA A receptor alpha subunit governs GABA potency. Neuropharmacology. 128. 408–415. 10 indexed citations
4.
Gacsályi, István, Katalin Nagy, György Lévay, et al.. (2012). Egis-11150: A candidate antipsychotic compound with procognitive efficacy in rodents. Neuropharmacology. 64. 254–263. 13 indexed citations
5.
Robotka, Hermina, Katalin Sas, Éva Rózsa, et al.. (2008). Neuroprotection achieved in the ischaemic rat cortex with l-kynurenine sulphate. Life Sciences. 82(17-18). 915–919. 33 indexed citations
6.
Sas, Katalin, Hermina Robotka, Éva Rózsa, et al.. (2008). Kynurenine diminishes the ischemia-induced histological and electrophysiological deficits in the rat hippocampus. Neurobiology of Disease. 32(2). 302–308. 47 indexed citations
7.
Gigler, Gábor, Gábor Szénási, György Lévay, et al.. (2007). Neuroprotective effect of L-kynurenine sulfate administered before focal cerebral ischemia in mice and global cerebral ischemia in gerbils. European Journal of Pharmacology. 564(1-3). 116–122. 72 indexed citations
8.
Gigler, Gábor, Mihály Albert, Mihály Végh, et al.. (2007). Neuroprotective and anticonvulsant effects of EGIS‐8332, a non‐competitive AMPA receptor antagonist, in a range of animal models. British Journal of Pharmacology. 152(1). 151–160. 17 indexed citations
9.
Jurányi, Zsolt, Gábor Gigler, György Lévay, et al.. (2006). Use of TTC staining for the evaluation of tissue injury in the early phases of reperfusion after focal cerebral ischemia in rats. Brain Research. 1116(1). 159–165. 151 indexed citations
10.
11.
Gressèns, Pierre, Michael Spedding, Gábor Gigler, et al.. (2005). The effects of AMPA receptor antagonists in models of stroke and neurodegeneration. European Journal of Pharmacology. 519(1-2). 58–67. 30 indexed citations
12.
Gigler, Gábor, et al.. (2004). Comparison of the AMPA Antagonist Action of New 2,3-Benzodiazepines in Vitro and Their Neuroprotective Effects in Vivo. Pharmaceutical Research. 21(2). 317–323. 13 indexed citations
13.
Gigler, Gábor, et al.. (2004). Reduction of cerebral infarct size by non-competitive AMPA antagonists in rats subjected to permanent and transient focal ischemia. Brain Research. 1019(1-2). 210–216. 27 indexed citations
14.
Hársing, László G., Gábor Gigler, Mihály Albert, et al.. (2004). Neurotransmitter Release in Experimental Stroke Models: The Role of Glutamate-Gaba Interaction. Advances in experimental medicine and biology. 541. 21–37. 7 indexed citations
15.
Szabados, Tamás, Gábor Gigler, István Gacsályi, István Gyertyán, & György Lévay. (2001). Comparison of anticonvulsive and acute neuroprotective activity of three 2,3-benzodiazepine compounds, GYKI 52466, GYKI 53405, and GYKI 53655. Brain Research Bulletin. 55(3). 387–391. 39 indexed citations
16.
Gadó, Klára, Gábor Gigler, Béla Tóth, et al.. (2001). Elevated Levels of Serum Prolactin in Patients with Advanced Multiple Myeloma. NeuroImmunoModulation. 9(4). 231–236. 11 indexed citations
17.
Szabados, Tamás, Gábor Gigler, István Gyertyán, István Gacsályi, & György Lévay. (1999). Duration of action of GYKI 52466 and its analogues in antiepileptic, anti-ischaemic and muscle relaxant tests.. PubMed. 7(1). 87–8. 2 indexed citations
18.
19.
Gadó, Klára & Gábor Gigler. (1991). Zymosan inflammation: A new method suitable for evaluating new antiinflammatory drugs. Inflammation Research. 32(1-2). 119–121. 27 indexed citations
20.
Gigler, Gábor, et al.. (1991). A New Antiinflammatory Agent (EGIS-5645) Without Gastrointestinal Side-Effect. Birkhäuser Basel eBooks. 32. 39–43.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitsuhiro Makino Breakdown of academic impact, for papers by Flóra Gölöncsér Breakdown of academic impact, for papers by Marina Alesiani Breakdown of academic impact, for papers by Kazuyuki Tomisawa Breakdown of academic impact, for papers by Michael A. Ackley Breakdown of academic impact, for papers by Helena Domin Breakdown of academic impact, for papers by Irena Romańska Breakdown of academic impact, for papers by Elena Meli Breakdown of academic impact, for papers by Maria Antonietta Stasi Breakdown of academic impact, for papers by Athanasios Metaxas
Rankless by CCL
2026